Ketamine for chronic non‐cancer pain: A meta‐analysis and trial sequential analysis of randomized controlled trials
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Ketamine has been suggested to be efficient in relieving chronic pain. However, there is inconsistency across studies investigating the effect of ketamine for chronic pain management. We aimed to perform a meta‐analysis in order to assess the efficacy of this compound during chronic non‐cancer pain conditions. Methods: The study consisted in a meta‐analysis of clinical trials comparing ketamine to a placebo during chronic non‐cancer pain. The primary endpoint of this study was pain relief 4 weeks after the beginning of treatment. Secondary outcomes were: pain relief 1, 2, 8 and 12 weeks after the beginning of treatment and incidence of psychedelic manifestations. Results: Six studies were included in this meta‐analysis. Overall, 99 patients received ketamine and 96 received placebo. Ketamine did not decrease pain intensity at 4 weeks (MD (on a 0 to 10 scale) = −1.12 [−2.33, 0.09], GRADE evidence: very low). However, analysing studies with no high‐risk bias found ketamine to decrease pain intensity at 4 weeks and increased the level of GRADE evidence to moderate. Trial sequential analysis confirmed the overall result and revealed the lack of power of this meta‐analysis. Ketamine also decreased pain intensity at all other evaluated points in time. Ketamine increased the incidence of psychedelic manifestations in comparison to placebo. Conclusion: Results of this meta‐analysis found moderate evidence suggesting the efficacy of ketamine during chronic pain. Further studies are warranted to conclude about the effect of ketamine during chronic pain conditions and to determine optimal administration regimes of this agent during this condition. Significance: Ketamine has been found interesting for managing chronic pain. We performed a meta‐analysis aiming to confirm those results. Ketamine was found efficient in alleviating pain up to 12 weeks after the beginning of treatment. However, overall evidence favouring the use of this compound was very low.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 1×
“This is supported by some evidences targeting the decrease in pain intensity to ≥2 when pharmacological interventions are considered (Forouzanfar et al., 2003; Olsen et al., 2017).”
BackgroundAlonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
How to obtain nnt from cohen’s D: comparison of two methods
Furukawa, T. A., & Leucht, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019070 · Cited by 179 · cited 2×
“…to harm (NNH) were calculated either directly for dichotomous data or estimated from the standardized mean difference (not displayed in results) when data were reported as continuous data, according to methodology described by Furukawa (1999; Furukawa and Leucht, 2011; Johnston et al., 2013).”
MethodInfluentialUse of oral ketamine in chronic pain management: A review
Blonk, M. I., Koder, B. G., van den Bemt, P. M. L. A., & Huygen, F. J. P. M. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.09.005 · Cited by 168
From effect size into number needed to treat
Furukawa, T. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01163-0 · Cited by 114
Cited by
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004185 · Cited by 179
Ketamine applications beyond anesthesia – A literature review
Nowacka, A., & Borczyk, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172547 · Cited by 129
Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial
Pickering, G., Pereira, B., Morel, V., Corriger, A., Giron, F., Marcaillou, F., Bidar-Beauvallot, A., Chandeze, E., Lambert, C., Bernard, L., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003345 · Cited by 69
Van Amsterdam, J., & Van Den Brink, W. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1949454 · Cited by 44
Ketamine for refractory chronic pain: a 1-year follow-up study
Corriger, A., Voute, M., Lambert, C., Pereira, B., & Pickering, G. (2022) · Pain · doi:10.1097/j.pain.0000000000002403 · Cited by 31
Metadata
- Authors
- Michelet, D., Brasher, C., Horlin, A. ‐., Bellon, M., Julien‐Marsollier, F., Vacher, T., Pontone, S., & Dahmani, S.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2017-11-26
- Volume
- 22
- Issue
- 4
- Pages
- 632-646
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2769944013
- Cited by
- 73
- References
- 7
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.